sCD14 in Gulf War Illness

In Gulf War Illness (GWI, Gulf War Syndrome), published studies report higher levels of sCD14, also described as Monocyte activation, than in healthy Gulf War veteran controls. Clinically, it has been associated with innate immune activation. The evidence summarised here comes from Gean et al. 2021 and reflects averages across cohorts rather than any single patient's result.

↑ ElevatedInflammatoryLOINC 30180-5

Summary

Direction in Gulf War Illness↑ Elevated — higher than in the comparison group
CategoryInflammatory
Also described asMonocyte activation
Compared againstHGV (healthy Gulf War veteran controls)
Associated symptomsInnate immune activation
Test typeBlood test (serum / plasma / whole blood)
LOINC code30180-5
SourceGean et al. 2021 — doi:10.1016/j.lfs.2021.119456
Condition atlasGulf War Illness Biomarker Atlas

Other conditions where sCD14 is reported

See the cross-condition hub: sCD14 across conditions.

Trials, interventions and tests

Commercial test availability

Soluble CD14 (sCD14) — specialty laboratory test. Research-oriented marker; limited routine availability.

Links are for reference only; availability, specimen requirements and coverage vary by location.

Related Inflammatory markers in Gulf War Illness

Full list: Gulf War Illness Biomarker Atlas.

Frequently asked questions

Is sCD14 high or low in Gulf War Illness?

Elevated. Studies summarised in the OSMF atlas report higher sCD14 in Gulf War Illness than in healthy Gulf War veteran controls. Source: Gean et al. 2021.

What symptoms is sCD14 associated with in Gulf War Illness?

The cited literature associates this marker with Innate immune activation. These are population-level associations and do not mean the marker causes the symptoms.

Which test measures sCD14?

It is measured as a blood test (serum / plasma / whole blood). The standard laboratory code is LOINC 30180-5. Commercial laboratories such as Mayo Clinic Laboratories list an orderable assay.

Is one abnormal sCD14 result diagnostic of Gulf War Illness?

No. No single biomarker is diagnostic of Gulf War Illness. sCD14 findings come from group comparisons, overlap considerably between patients and controls, and vary with study design, timing and comparison group. A result should be interpreted by a clinician alongside symptoms, history and other tests.

Is sCD14 specific to Gulf War Illness?

No. The same marker is also reported in Long COVID, ME/CFS in this atlas, so it reflects shared biology (for example inflammation or vascular stress) rather than a condition-specific signature.

Cite this page

Open Source Medicine Foundation. (2026). sCD14 in Gulf War Illness: direction, evidence and what it means. OSMF Research Tracker. Retrieved October 7, 2026, from https://research.opensourcemed.info/biomarkers/gulf-war-illness/scd14.html
Get OSMF research updates. New biomarker, trial and treatment evidence summaries by email.
Subscribe on Substack

Last reviewed: 2026-06-29 · Page generated from gulf-war-illness.json · Browse: Gulf War Illness atlas · Biomarker Index · All marker pages

Disclaimer: This page is an educational synthesis of published, peer-reviewed research and is not medical advice. Biomarker findings vary across studies with case definitions, comparison groups, timing and assay methods. Direction of change reflects the predominant finding in the cited source and does not establish a diagnostic threshold. Discuss any test result with a qualified clinician.